No Data
XIAOMI-W (01810.HK) plans to hold a Board of Directors meeting on May 27 to approve the first quarter performance.
Gelonghui reported on April 25 that XIAOMI-W (01810.HK) announced that the Board of Directors will hold a meeting on May 27, 2025 (Tuesday), during which the agenda includes considering and approving the unaudited consolidated first-quarter results of the company and its subsidiaries for the three months ended March 31, 2025.
Date of Board Meeting
Bank of America Securities: Reaffirms INNOVENT BIO (01810) 'Buy' rating and raises the Target Price to HKD 61.1.
In February of this year, INNOVENT BIO's sales of Darbepoetin and Bevacizumab were 0.179 billion and 0.114 billion yuan respectively, representing year-on-year increases of 47.6% and 32.3%, while the sales of Darunavir increased by 15.4% to 51.5 million yuan.
Humanoid robot competition: a "technical coming-of-age ceremony" where "flops" and "evolution" occur simultaneously.
① The champion team from Tian Gong, CTO Tang Jian of the Peking Humanoid Robot Innovation Center, told the Star Daily reporter, "The half marathon competition is mainly a limit test for the robot's Hardware and Software motion algorithm, or the stability and reliability of the robot's 'little brain'." ② The Wuxi embodied intelligence sports event opening tomorrow, along with the upcoming robot combat competition held by Yushu, will undoubtedly attract more attention for 'inspection.'
Market Chatter: Xiaomi Refutes Report of Delay in YU7 Electric SUV Launch
Market Chatter: Chinese Mutual Fund Holdings in Tencent Outshine CATL
Mysophobe : Voting rights